Jean‐Christophe Mozziconacci

Author

Also Known As

J.-C. Mozziconacci, Jean-Christophe Mozziconacci, Jean‐Christophe Mozziconacci

Publications

518

Citations

H-Index

Concepts

All Affiliations

Jean‐Christophe Mozziconacci is an author at Novartis (Switzerland) specializing in molecular docking, medicine, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	509
2	Engineering	2	2	384
3	Natural Sciences	2	2	125
4	Biostatistics	2	2	159
5	Biochemistry	1	1	39

Jean‐Christophe Mozziconacci

Publications

509

Citations

H-Index

Page 1

	Year	Citations
MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement Paulette A. Greenidge, Christian Krämer, Jean‐Christophe Mozziconacci, Journal of Chemical Information and Modeling Pdbbind Data SetAutomated ImplementationPhysicsData ScienceProtein Folding	2012	311
Improving Docking Results via Reranking of Ensembles of Ligand Poses in Multiple X-ray Protein Conformations with MM-GBSA Paulette A. Greenidge, Christian Krämer, Jean‐Christophe Mozziconacci, Journal of Chemical Information and Modeling X-ray CrystallographyProtein AssemblyMolecular BiologyLigand PosesProtein Folding	2014	86
2D QSAR Consensus Prediction for High-Throughput Virtual Screening. An Application to COX-2 Inhibition Modeling and Screening of the NCI Database Nicolas Baurin, Jean‐Christophe Mozziconacci, Éric Arnoult, Journal of Chemical Information and Computer Sciences Drug TargetEngineeringHit IdentificationCox-2 Inhibitor TrainingBiostatistics	2003	73
Optimization and Validation of a Docking-Scoring Protocol; Application to Virtual Screening for COX-2 Inhibitors Jean‐Christophe Mozziconacci, Éric Arnoult, Philippe Bernard, Journal of Medicinal Chemistry Bioorganic ChemistryPharmacotherapyChemical BiologyMedicinal ChemistryDocking-scoring Protocol	2005	39

Page 1